亚太药业(002370.SZ)：上半年净利润1.05亿元 同比增长1820.97%

Group 1 - The core viewpoint of the article is that Asia-Pacific Pharmaceutical (002370.SZ) reported a significant decline in revenue for the first half of 2025, while net profit showed a remarkable increase [1] - The company achieved operating revenue of 152 million yuan, representing a year-on-year decrease of 31.48% [1] - The net profit attributable to shareholders of the listed company was 105 million yuan, reflecting a year-on-year increase of 1,820.97% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -48.86 million yuan [1] - The basic earnings per share were reported at 0.14 yuan [1]